Bile Acid Metabolism in Health and Disease
Authors:
- 24 January 2020
- book chapter
- Published by Wiley
- p. 269-285
Abstract
No abstract availableKeywords
This publication has 143 references indexed in Scilit:
- Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10−/− miceNature, 2012
- Time-Restricted Feeding without Reducing Caloric Intake Prevents Metabolic Diseases in Mice Fed a High-Fat DietCell Metabolism, 2012
- FGF15/19 Regulates Hepatic Glucose Metabolism by Inhibiting the CREB-PGC-1α PathwayCell Metabolism, 2011
- Mouse Organic Solute Transporter α Deficiency Enhances Renal Excretion of Bile Acids and Attenuates CholestasisHepatology, 2009
- Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2 −/− mice†‡§Hepatology, 2009
- Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7α‐hydroxylase gene expression†Hepatology, 2008
- Sequence Alterations within CYP7B1 Implicate Defective Cholesterol Homeostasis in Motor-Neuron DegenerationThe American Journal of Human Genetics, 2008
- Human gut microbes associated with obesityNature, 2006
- Drug Insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasisNature Clinical Practice Gastroenterology & Hepatology, 2006
- Nonalcoholic Fatty Liver Disease: From Steatosis to CirrhosisHepatology, 2006